Maternal serum resistin at 11 to 13 weeks' gestation in normal and pathological pregnancies

Metabolism: Clinical and Experimental

Volumn 61, Issue 5, 2012, Pages 699-705

  Nanda, Surabhi ^a   Poon, Leona C Y ^a   Muhaisen, Mazen ^a   Acosta, Isabel C ^a   Nicolaides, Kypros H ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PREGNANCY ASSOCIATED PLASMA PROTEIN A; RESISTIN;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REPRODUCTION; SMALL FOR DATE INFANT; UTERINE ARTERY;

ADULT; BIRTH WEIGHT; DIABETES, GESTATIONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PLACENTATION; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; REFERENCE VALUES; RESISTIN;

EID: 84860246790     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2011.10.006     Document Type: Article

References (57)

1. S.R. Smith, F. Bai, and C. Charbonneau A promoter genotype and oxidative stress potentially link resistin to human insulin resistance Diabetes 52 2003 1611 1618
2. L. Patel, A.C. Buckels, and I.J. Kinghorn Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators Biochem Biophys Res Commun 300 2003 472 476
3. M. Degawa-Yamauchi, J.E. Bovenkerk, and B.E. Juliar Serum resistin (FIZZ3) protein is increased in obese humans J Clin Endocrinol Metab 88 2003 5452 5455
4. C.M. Steppan, S.T. Bailey, and S. Bhat The hormone resistin links obesity to diabetes Nature 409 2001 307 312
5. K.H. Kim, K. Lee, Y.S. Moon, and H.S. Sul A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation J Biol Chem 276 2001 11252 11256
6. N. Silswal, A.K. Singh, and B. Aruna Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway Biochem Biophys Res Commun 334 2005 1092 1101
7. P.G. McTernan, C.M. Kusminski, and S. Kumar Resistin Curr Opin Lipidol 17 2006 170 175
8. J.D. Knudson, G.M. Dick, and J.D. Tune Adipokines and coronary vasomotor dysfunction Exp Biol Med (Maywood) 232 2007 727 736
9. C.M. Kusminski, N.F. da Silva, and S.J. Creely The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes J Clin Endocrinol Metab 92 2007 270 276
10. D. Ribatti, M.T. Conconi, and G.G. Nussdorfer Nonclassic endogenous novel [corrected] regulators of angiogenesis Pharmacol Rev 59 2007 185 205
11. D.S. Mastrogiannis, M. Spiliopoulos, and W. Mulla Insulin resistance: the possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy Curr Diab Rep 9 2009 296 302
12. S. Riskin-Mashiah, G. Younes, and A. Damti First-trimester fasting hyperglycemia and adverse pregnancy outcomes Diabetes Care 32 2009 1639 1643
13. Catalano Obesity, insulin resistance, and pregnancy outcome Reproduction 140 2010 365 371
14. L.P. Lowe, B.E. Metzger, W.L. Lowe Jr HAPO Study Cooperative Research Group Inflammatory mediators and glucose in pregnancy: results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study J Clin Endocrinol Metab 95 2010 5427 5434
15. M.G. Dalfrà, G. Pacini, and E. Parretti Elevated insulin sensitivity and β-cell function during pregnancy in mothers of growth-restricted newborns Am J Physiol Endocrinol Metab 301 2011 E25 E30
16. S. Nanda, M. Savvidou, and A. Syngelaki Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks Prenat Diagn 31 2011 135 141
17. S. Nanda, C.K. Yu, and L. Giurcaneanu Maternal serum adiponectin at 11-13 weeks of gestation in preeclampsia Fetal Diagn Ther 29 2011 208 215
18. S. Nanda, R. Akolekar, and R. Sarquis Maternal serum adiponectin at 11 to 13 weeks of gestation in the prediction of macrosomia Prenat Diagn 31 2011 479 483
19. A.F. Ferreira, J.C. Rezende, and E. Vaikousi Maternal serum visfatin at 11-13 weeks of gestation in gestational diabetes mellitus Clin Chem 57 2011 609 613
20. S. Samolis, I. Papastefanou, and P. Panagopoulos Relation between first trimester maternal serum leptin levels and body mass index in normotensive and pre-eclamptic pregnancies-role of leptin as a marker of pre-eclampsia: a prospective case-control study Gynecol Endocrinol 26 2010 338 343
21. C. Qiu, M.A. Williams, and S. Vadachkoria Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus Obstet Gynecol 103 2004 519 525
22. S. Yura, N. Sagawa, and H. Itoh Resistin is expressed in the human placenta J Clin Endocrinol Metab 88 2003 1394 1397
23. Y. Zhou, M. Zhang, and W. Guo Expression of resistin protein in normal human subcutaneous adipose tissue and pregnant women subcutaneous adipose tissue and placenta J Huazhong Univ Sci Technolog Med Sci 26 2006 288 291
24. J.K. Nien, S. Mazaki-Tovi, and R. Romero Resistin: a hormone which induces insulin resistance is increased in normal pregnancy J Perinat Med 35 2007 513 521
25. S. Mazaki-Tovi, H. Kanety, and C. Pariente Insulin sensitivity in late gestation and early postpartum period: the role of circulating maternal adipokines Gynecol Endocrinol 27 2011 725 731
26. D. Chen, M. Dong, and Q. Fang Alterations of serum resistin in normal pregnancy and pre-eclampsia Clin Sci (Lond) 108 2005 81 84
27. D. Cortelazzi, S. Corbetta, and S. Ronzoni Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies Clin Endocrinol 66 2007 447 453
28. F. Haugen, T. Ranheim, and N.K. Harsem Increased plasma levels of adipokines in preeclampsia: relationship to placenta and adipose tissue gene expression Am J Physiol Endocrinol Metab 290 2006 E326 E333
29. H.J. Seol, M.J. Oh, and M.K. Yeo Comparison of serum levels and the placental expression of resistin between patients with preeclampsia and normal pregnant women Hypertens Pregnancy 29 2010 310 317
30. I. Hendler, S.C. Blackwell, and S.H. Mehta The levels of leptin, adiponectin, and resistin in normal weight, overweight, and obese pregnant women with and without preeclampsia Am J Obstet Gynecol 193 2005 979 983
31. N. Vitoratos, A. Deliveliotou, and A. Dimitrakaki Maternal serum resistin concentrations in gestational diabetes mellitus and normal pregnancies J Obstet Gynaecol Res 37 2011 112 118
32. M. Kuzmicki, B. Telejko, and J. Szamatowicz High resistin and interleukin-6 levels are associated with gestational diabetes mellitus Gynecol Endocrinol 25 2009 258 263
33. A. Megia, J. Vendrell, and C. Gutierrez Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition Eur J Endocrinol 158 2008 173 178
34. D. Chen, Q. Fang, and Y. Chai Serum resistin in gestational diabetes mellitus and early postpartum Clin Endocrinol (Oxf) 67 2007 208 211
35. E. Palik, E. Baranyi, and Z. Melczer Elevated serum acylated (biologically active) ghrelin and resistin levels associate with pregnancy-induced weight gain and insulin resistance Diabetes Res Clin Pract 76 2007 351 357
36. M. Lappas, K. Yee, M. Permezel, and G.E. Rice Release and regulation of leptin, resistin and adiponectin from human placenta, fetal membranes, and maternal adipose tissue and skeletal muscle from normal and gestational diabetes mellitus-complicated pregnancies J Endocrinol 186 2005 457 465
37. D.D. Briana, M. Boutsikou, and S. Baka Perinatal changes of plasma resistin concentrations in pregnancies with normal and restricted fetal growth Neonatology 93 2008 153 157
38. J. Wang, L.X. Shang, and X. Dong Relationship of adiponectin and resistin levels in umbilical serum, maternal serum and placenta with neonatal birth weight Aust N Z J Obstet Gynaecol 50 2010 432 438
39. K.Y. Lain, A.R. Daftary, R.B. Ness, and J.M. Roberts First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy Clin Endocrinol (Oxf) 69 2008 407 411
40. R.J. Snijders, P. Noble, and N. Sebire UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation Lancet 352 1998 343 346
41. K.O. Kagan, D. Wright, and A. Baker Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin, and pregnancy associated plasma protein-A Ultrasound Obstet Gynecol 31 2008 618 624
42. W. Plasencia, N. Maiz, and S. Bonino Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia Ultrasound Obstet Gynecol 30 2007 742 749
43. L.C. Poon, G. Karagiannis, and I. Staboulidou Reference range of birth weight with gestation and first-trimester prediction of small for gestation neonates Prenat Diagn 31 2011 58 65
44. M.A. Brown, M.D. Lindheimer, and M. de Swiet The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 20 2001 IX XIV
45. World Health Organisation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia; report of a WHO/IDF consultation 2006;1-46 [accessed September 2011 at http://www.who.int/diabetes/publications/en/ ].
46. K.O. Kagan, D. Wright, and A. Baker Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A Ultrasound Obstet Gynecol 31 2008 618 624
47. R. Akolekar, A. Syngelaki, and R. Sarquis Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks Prenat Diagn 31 2011 66 74
48. I.N. Holcomb, R.C. Kabakoff, and B. Chan FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family EMBO J 19 2000 4046 4055
49. N. Jansson, A. Nilsfelt, and M. Gellerstedt Maternal hormones linking maternal body mass index and dietary intake to birth weight Am J Clin Nutr 87 2008 1743 1749
50. I. Brosens, R. Pijnenborg, and L. Vercruysse The "great obstetrical syndromes" are associated with disorders of deep placentation Am J Obstet Gynecol 204 2011 193 201
51. C.K.H. Yu, G.C.S. Smith, and A.T. Papageorghiou An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low risk women Am J Obstet Gynecol 193 2005 429 436
52. L.J. Vatten, and R. Skjaerven Is pre-eclampsia more than one disease? BJOG 111 2004 298 302
53. R. D'Anna, G. Baviera, and F. Corrado Adiponectin and insulin resistance in early- and late-onset pre-eclampsia BJOG 113 2006 1264 1269
54. J.H. Lee, J.L. Chan, and N. Yiannakouris Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects J Clin Endocrinol Metab 88 2003 4848 4856
55. G. Karagiannis, R. Akolekar, and R. Sarquis Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks Fetal Diagn Ther 29 2011 148 154
56. J.B. Lawrence, C. Oxvig, M.T. Overgaard, L. Sottrup-Jensen, G.J. Gleich, and L.G. Hays The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A Proc Natl Acad Sci USA 96 1999 3149 3153
57. J.C. Irwin, L.F. Suen, N.A. Martina, S.P. Mark, and L.C. Giudice Role of the IGF system in trophoblast invasion and pre-eclampsia Hum Reprod 14 Suppl 2 1999 90 96